Agentic AI in Biopharma: Reimagining Life Science
Agentic AI is beginning to change how early-stage drug development really works by taking on the documentation burden that quietly slows innovation. In the U.S. biopharma ecosystem, the stakes couldn’t be higher. Bringing a new therapy from discovery to market often takes 10-15 years and can cost $2-3 billion per drug. At the same time, manufacturers are facing rising production costs, aggressive generic competition, and one of the most significant patent cliffs the industry has ever seen.